Search Results for 'CDMO'

---

Contract Service Directory Companies

View All Buyers Guide Companies »

---

Contract Service Directory Categories

View All Categories »

---

• cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development
  

  Integrating CDMO and CRO Services

  Mark Egerton explains the importance of integrating formulation development and adaptive manufacturing with clinical research

  Online Exclusives Kristin Brooks, Managing Editor 09.04.18
  

  ---

• Bio News | Biosimilars | Breaking News | Industry News
  

  Oncobiologics Enters First CDMO Contract

  Officially launches BioSymphony Platform-based CDMO business

  06.18.18
  

  ---

• cGMP Manufacture
  

  Changing Dynamics: The CDMO market in focus

  Contract Pharma talks with executives about trends in the CDMO market

  Tim Wright, Editor, Contract Pharma 04.10.18
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  iBio Expands CDMO Capabilities

  To include the development and cGMP manufacturing of Fc fusion proteins

  03.08.18
  

  ---

• 

  CMO/CDMO Sector Mega-Mergers & Acquisitions

  A look at recent M&A activity among contract service providers

  Kristin Brooks, Contract Pharma 11.07.17
  

  ---

• Industry News
  

  CPhI Report Highlights Anticipated CDMO Market Trends

  Niche services and technologies to dominate future acquisitions, increase in flow chemistry, fermentation anticipated

  10.17.17
  

  ---

• 

  Outsourcing Partnerships: Trends in the CDMO Sector

  The market for outsourcing services is growing faster than the pharmaceutical industry as a whole.

  Tim Wright, Contract Pharma 09.06.17
  

  ---

• Regulatory Affairs | Serialization
  

  The Challenge of Serialization: A CDMO Perspective

  What should pharma company’s expect from their service provider partners?

  Staffan Widengren, Director Corporate Projects, Recipharm 09.08.16
  

  ---

• Analytical Services | Biosimilars | Clinical Trials | Drug Development | Formulation Development

  Why True CDMO Service Requires Flexibility, Responsiveness and Innovation

  Pharmaceutical and biopharmaceutical companies large and small are increasingly relying on third-party providers for support at all stages of drug development. To realize efficiencies, they are at the same time reducing the number of suppliers to a preferred few with whom they can form strategic partnerships.

  James E. Gregory, UPM Pharmaceuticals 10.07.15
  

  ---